JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.16B |
| 2 |
Microsoft
MSFT
|
+$2.29B |
| 3 |
Amazon
AMZN
|
+$2B |
| 4 |
UnitedHealth
UNH
|
+$1.76B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.42B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.61B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$689M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$659M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$647M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.28% |
| 2 | Technology | 15.04% |
| 3 | Healthcare | 12.52% |
| 4 | Financials | 10.55% |
| 5 | Consumer Discretionary | 7.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
PDCO
1676
DELISTED
Patterson Companies, Inc.
PDCO
| $17M | ﹤0.01% |
562,104
-61,520
| -10% | -$1.93M |
2013 Q2
36 quarters
|
|
1677
Lantheus
LNTH
$6.51B
| $17M | ﹤0.01% |
257,557
+19,301
| +8% | +$1.22M |
2016 Q4
22 quarters
|
|
1678
Sabra Healthcare REIT
SBRA
$4.9B
| $17M | ﹤0.01% |
1,216,045
-1,242,361
| -51% | -$16.6M |
2015 Q3
27 quarters
|
|
1679
Krystal Biotech
KRYS
$9.63B
| $17M | ﹤0.01% |
258,567
+706
| +0.3% | +$43.9K |
2018 Q2
16 quarters
|
|
1680
Macy's
M
$5.94B
| $17M | ﹤0.01% |
926,605
-1,269,637
| -58% | -$28.7M |
2013 Q2
36 quarters
|
|
1681
Everest Group
EG
$14.1B
| $16.9M | ﹤0.01% |
60,450
+12,990
| +27% | +$3.67M |
2013 Q2
36 quarters
|
|
1682
iShares Semiconductor ETF
SOXX
$49.1B
| $16.9M | ﹤0.01% |
145,377
+132,927
| +1,068% | +$17.9M |
2015 Q2
28 quarters
|
|
1683
Lumentum
LITE
$93.8B
| $16.9M | ﹤0.01% |
212,701
+22,948
| +12% | +$1.96M |
2015 Q3
27 quarters
|
|
1684
CALL
Enterprise Products Partners
EPD
$77B
| $16.8M | ﹤0.01% |
690,400
+352,100
| +104% | +$9.26M |
2021 Q2
4 quarters
|
|
1685
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.76B
| $16.8M | ﹤0.01% |
398,796
-112,894
| -22% | -$4.86M |
2015 Q1
29 quarters
|
|
1686
Janus International
JBI
$569M
| $16.8M | ﹤0.01% |
1,862,296
-95,976
| -5% | -$932K |
2021 Q4
2 quarters
|
|
1687
AB InBev
BUD
$144B
| $16.8M | ﹤0.01% |
311,632
+299,329
| +2,433% | +$16.8M |
2013 Q2
36 quarters
|
|
1688
iShares Preferred and Income Securities ETF
PFF
$12.4B
| $16.8M | ﹤0.01% |
511,281
+30,557
| +6% | +$1.03M |
2013 Q2
36 quarters
|
|
1689
FTI Consulting
FCN
$3.91B
| $16.8M | ﹤0.01% |
92,950
-17,598
| -16% | -$2.9M |
2013 Q2
36 quarters
|
|
|
PING
1690
DELISTED
Ping Identity Holding Corp.
PING
| $16.8M | ﹤0.01% |
926,306
+13,395
| +1% | +$298K |
2019 Q4
10 quarters
|
|
1691
Vericel Corp
VCEL
$2.02B
| $16.8M | ﹤0.01% |
666,922
-9,882
| -1% | -$292K |
2018 Q1
17 quarters
|
|
1692
First Solar
FSLR
$18.5B
| $16.8M | ﹤0.01% |
246,274
+9,471
| +4% | +$674K |
2013 Q2
36 quarters
|
|
1693
TriCo Bancshares
TCBK
$1.66B
| $16.7M | ﹤0.01% |
366,474
+343,461
| +1,492% | +$14.5M |
2014 Q4
30 quarters
|
|
1694
Meritage Homes
MTH
$4.2B
| $16.7M | ﹤0.01% |
459,660
+41,680
| +10% | +$1.66M |
2015 Q4
26 quarters
|
|
|
SPLK
1695
DELISTED
Splunk Inc
SPLK
| $16.7M | ﹤0.01% |
188,249
+137,544
| +271% | +$15.1M |
2013 Q2
36 quarters
|
|
1696
A.O. Smith
AOS
$7.7B
| $16.6M | ﹤0.01% |
304,264
-36,113
| -11% | -$2.17M |
2013 Q2
36 quarters
|
|
1697
Malibu Boats
MBUU
$449M
| $16.6M | ﹤0.01% |
315,611
-16,447
| -5% | -$893K |
2014 Q1
33 quarters
|
|
1698
Invesco MSCI Sustainable Future ETF
ERTH
$122M
| $16.6M | ﹤0.01% |
309,450
+886
| +0.3% | +$49.3K |
2021 Q4
2 quarters
|
|
|
ONC
1699
BeOne Medicines Ltd
ONC
$40.6B
| $16.6M | ﹤0.01% |
102,619
-13,779
| -12% | -$2.15M |
2017 Q4
18 quarters
|
|
1700
CALL
Palo Alto Networks
PANW
$324B
| $16.5M | ﹤0.01% |
201,000
| – | – |
2021 Q1
5 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2022 Portfolio in Review
As of Q2 2022, JP Morgan Chase held 7,270 positions worth $718B, down 14% from $830B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2022 filing shows 568 new, 2,561 increased, 2,728 reduced and 609 closed positions. Its largest new stake was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B. The largest sale was JPMorgan BetaBuilders Europe ETF, an estimated $4.61B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q2 2022 buy was JPMorgan International Research Enhanced Equity ETF: 85,906,762 shares worth $4.15B.
- JP Morgan Chase added most to Microsoft in Q2 2022, an estimated $2.29B increase.
- JP Morgan Chase's biggest Q2 2022 reduction was JPMorgan BetaBuilders Europe ETF, cutting an estimated $4.61B.
- JP Morgan Chase fully exited Cerner Corp in Q2 2022, selling an estimated $608M.
- JP Morgan Chase's ten largest holdings make up 18% of its $718B portfolio in Q2 2022.
- JP Morgan Chase opened 568 new positions and closed 609 in Q2 2022.
- JP Morgan Chase's portfolio value fell 14% quarter-over-quarter to $718B.
Based on JP Morgan Chase's 13F filing for Q2 2022, filed 11 Aug 2022.